OVERCOMING ENZALUTAMIDE-RESISTANT WITH A NOVEL ANTI-AR PEPTIDE IN PROSTATE CANCER CELLS

被引：0
|
作者：
Zainfeld, Daniel
Chen, Ruibao
Thrasher, J. Brantley
Li, Benyi
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.2238
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP84-14
引用
收藏
页码：E1095 / E1095
页数：1
相关论文
共 50 条
  • [31] A Pyrrole-Imidazole Polyamide Is Active against Enzalutamide-Resistant Prostate Cancer
    Kurmis, Alexis A.
    Yang, Fei
    Welch, Timothy R.
    Nickols, Nicholas G.
    Dervan, Peter B.
    CANCER RESEARCH, 2017, 77 (09) : 2207 - 2212
  • [32] Aberrant tumor metabolism enables GR takeover in enzalutamide-resistant prostate cancer
    Li, Jianneng
    CANCER RESEARCH, 2017, 77
  • [33] MCT inhibition as a therapeutic strategy to target Enzalutamide-resistant prostate cancer.
    Bhattacharjee, Sayani
    Doan, Jonathan
    Wynn, Rebecca
    Nadiminty, Nagalakshmi
    CANCER RESEARCH, 2021, 81 (13)
  • [34] Multivalent peptoid conjugates suppress enzalutamide-resistant prostate cancer cellular proliferation
    Wang, Yu
    Levine, Paul
    Dehigaspitiya, Dilani
    Profit, Adam
    Logan, Susan
    Imberg-Kazdan, Keren
    Kirshenbaum, Kent
    Garabedian, Michael
    CANCER RESEARCH, 2016, 76
  • [35] Daclatasvir, an Antiviral Drug, Downregulates Tribbles 2 Pseudokinase and Resensitizes Enzalutamide-Resistant Prostate Cancer Cells
    Monga, Jitender
    Valeriote, Frederick
    Hwang, Clara
    Gadgeel, Shirish
    Ghosh, Jagadananda
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (03) : 381 - 392
  • [36] Combination AZD5363 with Enzalutamide Significantly Delays Enzalutamide-resistant Prostate Cancer in Preclinical Models
    Toren, Paul
    Kim, Soojin
    Cordonnier, Thomas
    Crafter, Claire
    Davies, Barry R.
    Fazli, Ladan
    Gleave, Martin E.
    Zoubeidi, Amina
    EUROPEAN UROLOGY, 2015, 67 (06) : 986 - 990
  • [37] Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer
    Erb, Holger H. H.
    Bodenbender, Julia
    Handle, Florian
    Diehl, Tamara
    Donix, Lukas
    Tsaur, Igor
    Gleave, Martin
    Haferkamp, Axel
    Huber, Johannes
    Fuessel, Susanne
    Juengel, Eva
    Culig, Zoran
    Thomas, Christian
    PLOS ONE, 2020, 15 (08):
  • [38] Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer
    Kang, Borui
    Mottamal, Madhusoodanan
    Zhong, Qiu
    Bratton, Melyssa
    Zhang, Changde
    Guo, Shanchun
    Hossain, Ahamed
    Ma, Peng
    Zhang, Qiang
    Wang, Guangdi
    Payton-Stewart, Florastina
    PHARMACEUTICALS, 2023, 16 (05)
  • [39] BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer
    Luk, Iris Sze Ue
    Shrestha, Raunak
    Xue, Hui
    Wang, Yuwei
    Zhang, Fang
    Lin, Dong
    Haegert, Anne
    Wu, Rebecca
    Dong, Xin
    Collins, Colin C.
    Zoubeidi, Amina
    Gleave, Martin E.
    Gout, Peter W.
    Wang, Yuzhuo
    CLINICAL CANCER RESEARCH, 2017, 23 (06) : 1542 - 1551
  • [40] Biomarker Analysis of Men With Enzalutamide-Resistant Metastatic Castration-Resistant Prostate Cancer Treated With Pembrolizumab
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (11) : 15 - 16
12345